Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Maurya, Dharmendra K ^a   Doi, Chiyo ^a   Kawabata, Atsushi ^a   Pyle, Marla M ^a   King, Clay ^a   Wu, Zhihong ^a   Troyer, Deryl ^a   Tamura, Masaaki ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CYCLIN A; CYCLIN DEPENDENT KINASE 2; THYMIDINE; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CANCER SURVIVAL; CELL ASSAY; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; COCULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DNA SYNTHESIS; FEMALE; HISTOPATHOLOGY; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; ISOGRAFT; LEWIS CARCINOMA; LUNG ADENOCARCINOMA; LUNG WEIGHT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; THERAPY EFFECT; TUMOR VOLUME; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; HUMAN; LUNG TUMOR; METHODOLOGY; STEM CELL; UMBILICAL CORD;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, LEWIS LUNG; CELLS, CULTURED; COCULTURE TECHNIQUES; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; RATS; STEM CELLS; UMBILICAL CORD;

EID: 77958548514     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-590     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics, 2009. CA Cancer J Clin 2009,
2. Johnson DH, Schiller JH. Novel therapies for the treatment of non-small cell lung cancer. Cancer Chemother Biol Response Modif 2002, 20:763-786.
3. Lynch TJ, Adjei AA, Bunn PA, DuBois RN, Gandara DR, Giaccone G, Govindan R, Herbst RS, Johnson BE, Khuri FR, et al. Novel agents in the treatment of lung cancer: conference summary statement. Clin Cancer Res 2004, 10(12 Pt 2):4199s-4204s. 10.1158/1078-0432.CCR-040021, 15217958.
4. Corsten MF, Shah K. Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. Lancet Oncol 2008, 9(4):376-384. 10.1016/S1470-2045(08)70099-8, 18374291.
5. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000, 97(23):12846-12851. 10.1073/pnas.97.23.12846, 18852, 11070094.
6. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005, 65(8):3307-3318.
7. Rachakatla RS, Marini F, Weiss ML, Tamura M, Troyer D. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther 2007, 14(10):828-835. 10.1038/sj.cgt.7701077, 17599089.
8. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002, 62(13):3603-3608.
9. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004, 96(21):1593-1603. 10.1093/jnci/djh299, 15523088.
10. Aboody KS, Najbauer J, Schmidt NO, Yang W, Wu JK, Zhuge Y, Przylecki W, Carroll R, Black PM, Perides G. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol 2006, 8(2):119-126. 10.1215/15228517-2005-012, 1871940, 16524944.
11. Kumar S, Chanda D, Ponnazhagan S. Therapeutic potential of genetically modified mesenchymal stem cells. Gene Ther 2008, 15(10):711-715. 10.1038/gt.2008.35, 18356815.
12. Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T, et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 2003, 21(1):50-60.
13. Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, Lo DP, Harris IR, Popma SH, Sachs DH, Huang CA. Immunogenicity of umbilical cord tissue derived cells. Blood 2008, 111(1):430-438. 10.1182/blood-2007-03-078774, 17909081.
14. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D, McIntosh KR. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008, 26(11):2865-2874. 10.1634/stemcells.2007-1028, 18703664.
15. Ganta C, Chiyo D, Ayuzawa R, Rachakatla R, Pyle M, Andrews G, Weiss M, Tamura M, Troyer D. Rat umbilical cord stem cells completely abolish rat mammary carcinomas with no evidence of metastasis or recurrence 100 days post-tumor cell inoculation. Cancer Res 2009, 69(5):1815-1820. 10.1158/0008-5472.CAN-08-2750, 19244122.
16. Ayuzawa A, Doi C, Rachakatla RS, Pyle MM, Maurya DK, Troyer D, Tamura M. Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo. Cancer letters 2009, 280(1):31-37. 10.1016/j.canlet.2009.02.011, 2914472, 19285791.
17. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II, Nguyen AT, Malide D, Combs CA, Hall G, et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006, 203(5):1235-1247. 10.1084/jem.20051921, 2121206, 16636132.
18. Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther 2008, 15(10):739-752. 10.1038/gt.2008.41, 18369324.
19. Hall B, Andreeff M, Marini F. The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 2007, (180):263-283. full_text, 17554513.
20. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410(6824):50-56. 10.1038/35065016, 11242036.
21. Lee BC, Lee TH, Avraham S, Avraham HK. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2004, 2(6):327-338.
22. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449(7162):557-563. 10.1038/nature06188, 17914389.
23. Arbab AS, Janic B, Knight RA, Anderson SA, Pawelczyk E, Rad AM, Read EJ, Pandit SD, Frank JA. Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings. Faseb J 2008, 22(9):3234-3246. 10.1096/fj.07-105676, 2518252, 18556461.
24. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G, Troyer D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24(3):781-792. 10.1634/stemcells.2005-0330, 16223852.
25. Weiss ML, Troyer DL. Stem cells in the umbilical cord. Stem Cell Rev 2006, 2(2):155-162. 10.1007/s12015-006-0022-y, 17237554.